Denali Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
SOUTH SAN FRANCISCO, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a...
Therapeutics
Oncternal Therapeutics to Report Very first Quarter 2021 Fiscal Success and Give Enterprise Update
SAN DIEGO, April 29, 2021 (World NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a medical-phase biopharmaceutical business centered on the...
G1 Therapeutics to Supply First Quarter 2021 Money Effects and Company Update on May 5, 2021
BloombergBond Traders Choose At any time-Riskier Bets in Hunt for Returns(Bloomberg) -- Bond buyers, emboldened by a recovering financial system...
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
- Granted Priority Medicines designation by the European Medicines Agency for CTX001™ for transfusion-dependent beta thalassemia (TDT)--More than 30 patients...
Peptide Cancer Therapy Market Therapeutics Drug Revenue Patent Price tag USD 20 Billion Option 2026
BloombergEurope’s Most Indebted Nations around the world Are not All set for Sector Reality(Bloomberg) -- Europe’s brightening economic outlook as...
Plus Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
Management to host conference call today at 5:00 pm ETAUSTIN, Texas, April 22, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc....
Aquestive Therapeutics to Report To start with Quarter 2021 Money Success and Latest Business Highlights on May possibly 4 and Host Meeting Call on May 5 at 8:00 a.m. ET
WARREN, N.J., April 21, 2021 (Globe NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical organization centered on producing and...
Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2020
BloombergCentral Banks to Pour Money Into Economy Despite Sharp Rebound(Bloomberg) -- The aggressive rebound in global economic growth still isn’t...
Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Fiscal Officer
TipRanks3 “Strong Buy” Dividend Stocks Yielding Close to 7%These past 12 months have observed the S&P 500 return its very...
Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Fiscal Officer
SAN DIEGO, April 19, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company targeted on growth and commercialization in Higher...
Human Microbiome Therapeutics Marketplace Report 2021-2031
Forecasts by Engineering (Genomics, Proteomics, Metabolomics), by Therapeutic Area (Neurological Disorders, Dermatological Indications, Cancers, Metabolic Problems, Gastrointestinal Problems, Other Therapeutic...
Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
SEATTLE, April 07, 2021 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development...
Inspyr Therapeutics Reports Financial Results and Business Update For Full Year 2020
Implements new corporate strategy to focus on precision therapeutics for the treatment of cancer Strengthens pipeline by acquiring a proprietary...
Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates
WARRINGTON, Pa., March 29, 2021 /PRNewswire/ -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on...
Frequency Therapeutics Provides Business Updates and Reports Fourth Quarter and Full Year 2020 Financial Results
BloombergBig Oil’s Secret World of Trading(Bloomberg Markets) -- It was a bleak moment for the oil industry. U.S. shale companies...
Trispecific Antibody Anticancer Therapeutics Market place USD 2 Billion Prospect By 2024
Trispecific Antibodies to Discover Subsequent Period Of Designer Antibodies Market place States Kuick StudyNEW DELHI, March 24, 2021 /PRNewswire/ --...
Sigilon Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional...
LogicBio Therapeutics Reports Full Year 2020 Financial Results and Provides Business Update
- First patient for Phase 1/2 SUNRISE trial expected to be enrolled in early 2021-Translational preclinical data for sAAVy platform...
